Centre for International Child Health, MCRI, Royal Children's Hospital, University of Melbourne, Parkville, Victoria, Australia.
Department of Paediatrics, University College Hospital, Ibadan, Nigeria.
Pediatr Pulmonol. 2020 Jun;55 Suppl 1(Suppl 1):S37-S50. doi: 10.1002/ppul.24691. Epub 2020 Feb 19.
Pneumonia and malaria are the leading causes of global childhood mortality. We describe the clinical presentation of children diagnosed with pneumonia and/or malaria, and identify possible missed cases and diagnostic predictors.
Prospective cohort study involving children (aged 28 days to 15 years) admitted to 12 secondary-level hospitals in south-west Nigeria, from November 2015 to October 2017. We described children diagnosed with malaria and/or pneumonia on admission and identified potential missed cases using WHO criteria. We used logistic regression models to identify associations between clinical features and severe pneumonia and malaria diagnoses.
Of 16 432 admitted children, 16 184 (98.5%) had adequate data for analysis. Two-thirds (10 561, 65.4%) of children were diagnosed with malaria and/or pneumonia by the admitting doctor; 31.5% (567/1799) of those with pneumonia were also diagnosed with malaria. Of 1345 (8.3%) children who met WHO severe pneumonia criteria, 557 (41.4%) lacked a pneumonia diagnosis. Compared with "potential missed" diagnoses of severe pneumonia, children with "detected" severe pneumonia were more likely to receive antibiotics (odds ratio [OR], 4.03; 2.63-6.16, P < .001), and less likely to die (OR, 0.72; 0.51-1.02, P = .067). Of 2299 (14.2%) children who met WHO severe malaria criteria, 365 (15.9%) lacked a malaria diagnosis. Compared with "potential missed" diagnoses of severe malaria, children with "detected" severe malaria were less likely to die (OR, 0.59; 0.38-0.91, P = 0.017), with no observed difference in antimalarial administration (OR, 0.29; 0.87-1.93, P = .374). We identified predictors of severe pneumonia and malaria diagnosis.
Pneumonia should be considered in all severely unwell children with respiratory signs, regardless of treatment for malaria or other conditions.
肺炎和疟疾是全球儿童死亡的主要原因。我们描述了被诊断患有肺炎和/或疟疾的儿童的临床表现,并确定了可能的漏诊病例和诊断预测因素。
这是一项前瞻性队列研究,纳入了 2015 年 11 月至 2017 年 10 月期间在尼日利亚西南部 12 所二级医院住院的 28 天至 15 岁儿童。我们描述了入院时被诊断患有疟疾和/或肺炎的儿童,并使用世界卫生组织(WHO)标准确定了潜在的漏诊病例。我们使用逻辑回归模型来确定临床特征与严重肺炎和疟疾诊断之间的关联。
在 16432 名入院儿童中,有 16184 名(98.5%)儿童有足够的数据进行分析。三分之二(10561 名,65.4%)的儿童由主治医生诊断为疟疾和/或肺炎;其中 31.5%(567/1799)患有肺炎的儿童也被诊断患有疟疾。在 1345 名(8.3%)符合 WHO 严重肺炎标准的儿童中,有 557 名(41.4%)未被诊断为肺炎。与“潜在漏诊”的严重肺炎相比,“已检出”严重肺炎的儿童更有可能接受抗生素治疗(比值比[OR],4.03;2.63-6.16,P<0.001),且不太可能死亡(OR,0.72;0.51-1.02,P=0.067)。在 2299 名(14.2%)符合 WHO 严重疟疾标准的儿童中,有 365 名(15.9%)未被诊断为疟疾。与“潜在漏诊”的严重疟疾相比,“已检出”严重疟疾的儿童死亡的可能性更低(OR,0.59;0.38-0.91,P=0.017),抗疟药物的使用也没有差异(OR,0.29;0.87-1.93,P=0.374)。我们确定了严重肺炎和疟疾诊断的预测因素。
对于所有有严重呼吸系统症状且无论是否接受疟疾或其他治疗的严重不适儿童,均应考虑肺炎的可能。